Posted in | News | Business | 3D Printing

Puget Provides Analysis on 3D Printing Market

Puget Technologies, an emerging 3D printer and software company for the consumer market, today provided the following comments from its President and CEO Ron Leyland regarding recent 3D market analysis and events.

Keith Kmetz, Vice President at International Data Corporation (IDC), the premier global provider of market intelligence, reported, “While traditional print technologies are facing maturity, 3D printers will see worldwide unit shipments grow by 10 times over the forecast period, and worldwide hardware value will more than double in the short term.” IDC’s forecast period is between now and 2017.

In 2013, the 3D printing market experienced consolidation and acquisition by the major players. This past year also saw unique business models and subsequent competitors like Puget emerge. Coupled with the fact that a number of patents controlling the process of laser sintering are set to expire in 2014, fresh opportunities for the new home 3D printer are on the horizon for this year.

Commenting on developments, President and CEO of Puget Technologies Ron Leyland said, “We expect Puget could become more aggressive on joint venture and partner opportunities to shore up its strategic position, which could negatively pressure competitor’s momentum in the space. In our opinion, there are a number of new market entrants in the 3D software and consumables technologies market that make consolidation less of a play in 2014.”

Puget’s 3D printing division, along with Stratasys (SSYS), 3D Systems (DDD), and ExOne (XONE), is expected to benefit from investors' expectations of solid announcements coming out of the Consumer Electronics Show next week in Las Vegas, Nevada.

Details about Puget’s 3D printer division can be found at http://www.pugettechinc.com.

Source: http://www.pugettechinc.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.